1800 202 8726
After radiotherapy

FDG Uptake After Radiotherapy: — Inflammation or Disease?

A PET scan showing uptake where you were treated is frightening. Radiation inflames tissue — and inflammation is metabolically active, which is exactly what PET-CT measures. A finding in a treated area is not a diagnosis. It is the start of a clinical question.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

  • Inflammation lights up on PET — Radiation damages tissue and triggers an immune response. That response shows up on PET scans the same way cancer does.
  • Timing changes the picture — The sooner after treatment a scan is done, the more likely uptake reflects inflammation rather than disease.
  • Pattern matters — Uptake within the radiation field is interpreted differently from uptake in a new location.
  • Your team decides, not the scan alone — A PET finding is one input. Your oncologist combines it with your clinical picture before drawing any conclusion.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

FDG uptake in a treated area after radiotherapy can be radiation-induced inflammation, not disease returning. Radiation damages tissue and that damage is metabolically active — which PET-CT measures. NCCN, ASCO and ESMO guidance treats a post-treatment PET finding as needing careful interpretation alongside timing, pattern, and your clinical picture — not as a standalone diagnosis.

PET-CT at CION starts from Rs 10,499 — among the lowest published prices in Hyderabad, with no hidden charges. Indicative price, as of September 2026.

Why does radiation cause FDG uptake on a PET scan?

Radiotherapy damages tissue to kill cancer cells. That damage triggers an inflammatory response — and inflammation consumes glucose, which is exactly what PET-CT measures.

The signal looks the same on the scan as active cancer: bright, FDG-avid uptake in the treated zone. This is called post-radiation uptake, and it is one of the main reasons a PET result in a treated area is never read in isolation.

What does my team look at when there is uptake in the treated area?

  • How much time has passed since radiotherapy ended
  • Whether the uptake is inside the radiation field or in a new location
  • How the pattern compares to your previous scans
  • Whether you have symptoms that either cause would explain
  • Whether the shape of the uptake follows the geometry of the radiation field
  • What the CT component of the scan shows alongside the PET signal

How long does post-radiation inflammation last on a PET scan?

The duration varies by person and by organ. Lung tissue tends to show inflammatory changes for longer than mucous membranes such as the throat or gullet.

Because of this variation, a single post-treatment scan showing uptake is rarely the final answer. Your team may recommend a follow-up scan after an agreed interval to see whether the signal has settled, persisted, or grown.

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

PET-CT Partner Centres

PET-CT Scan Centres in Hyderabad

CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.

These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

When is it safe to do a PET scan after finishing radiotherapy?

NCCN, ASCO and ESMO guidance recommends waiting several months after completing radiotherapy before performing a response-assessment PET-CT. Scanning too soon — before the acute inflammatory response has settled — increases the chance of a misleading result.

The exact interval depends on your cancer type and the organ treated. If you are unsure why your scan was arranged when it was, ask your oncologist what interval was applied and how that affects the interpretation.

What happens after uptake is found on a post-treatment scan?

  1. The radiologist reports the finding in context

    The report notes whether uptake is within the radiation field and comments on the degree of suspicion. The radiologist does not make the clinical decision — that rests with your treating team.

  2. Your oncologist reviews with your full history

    They compare the scan to your previous imaging, factor in your symptoms and clinical examination, and weigh the timing against known patterns of post-radiation change.

  3. A plan is agreed: watch closely or investigate further

    If the pattern is consistent with inflammation and you are clinically well, a repeat scan after an agreed interval is often the next step rather than immediate action.

  4. Biopsy if imaging cannot give a clear answer

    Where the finding cannot be distinguished from disease on imaging alone, tissue sampling removes the uncertainty. Your team will explain whether and where this is feasible.

Does uptake in a treated area always mean the cancer is back?

No — but the scan alone cannot tell you which it is

Uptake in a treated area is common after radiotherapy and is frequently inflammatory, particularly in the months following treatment. What a scan alone cannot determine is whether your specific finding is benign or malignant. That is the question your team is working through. Tissue confirmation is what resolves it when imaging leaves genuine doubt.

Can the doctor tell just by looking at the scan?

Experienced nuclear medicine physicians can often say a pattern looks more consistent with inflammation than disease, or the reverse. But that is a probability, not a certainty. Pattern, timing, and your clinical picture together raise or lower suspicion — they do not eliminate it. Where the result would change your treatment, tissue sampling provides the certainty that imaging cannot.

What if we scan again instead of doing a biopsy?

A repeat scan after an agreed interval is often appropriate when the clinical picture is reassuring. If uptake decreases or disappears on the follow-up scan, that supports an inflammatory cause. If it persists or grows, the case for biopsy strengthens. Your team will tell you whether watchful imaging suits your situation or whether more urgent investigation is needed.

What if the uptake is outside the radiation field?

Uptake outside the radiation field cannot be attributed to post-treatment inflammation from that treatment. It needs a separate explanation — which may still be benign, such as infection, but it cannot be dismissed as radiation-related. The threshold for further investigation at a new site is generally lower than for an in-field finding, and your team will approach the two differently.

My report mentions a high SUV. Does that mean it is cancer?

Not on its own. SUV — standardised uptake value — measures how much glucose the tissue is consuming. Active inflammation can produce high SUV values. The number is one factor your team uses alongside pattern, location, and timing. It is not a standalone indicator and should not be read as one without everything else your team knows about your situation.

A whole-body PET-CT at CION is Rs 10,499 — among the lowest published prices in Hyderabad — with a free Rs 950 oncologist consultation to talk through your report. Indicative price, as of September 2026.

Explore 94 more Understanding Your PET-CT Report topics

All Understanding Your PET-CT Report →

Your next step

Talk to an oncologist about your scan

Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Can a PET scan after radiotherapy show a false positive?

Yes, and this is one of the most important limitations of post-treatment PET imaging. Radiation causes inflammation, and inflammation produces FDG uptake that can look identical to cancer on the scan. NCCN and ESMO guidance identifies this risk specifically: early post-treatment scans are more likely to produce a misleading positive result. A positive finding in a treated area requires careful interpretation alongside your full clinical picture — not a conclusion on its own.

How will my team tell whether the uptake is inflammation or disease?

They use several things together: time elapsed since treatment ended; whether the uptake is inside the radiation field or in a new location; how it compares to previous scans; and whether you have relevant symptoms. No single factor decides. If genuine doubt remains and the result would change your treatment, biopsy is the step that resolves it. Imaging raises or lowers suspicion — only tissue gives a definitive answer.

How long after radiotherapy should we wait before doing a PET scan?

NCCN, ASCO and ESMO recommend waiting several months after completing radiotherapy before a response-assessment PET-CT. The reason is to allow the acute inflammatory response to settle so that the result can be interpreted reliably. Your oncologist sets the specific timing based on your cancer type and the organ treated. If a scan was arranged sooner — because of new symptoms, for example — ask your team how the shorter interval affects their interpretation.

Should we get a second opinion on the scan?

A second opinion from another nuclear medicine physician is always reasonable, especially when the finding is ambiguous or the decision it leads to is significant. Ask your oncologist whether a multidisciplinary tumour board review has already been done — where the nuclear medicine physician, radiologist, and treating team discuss the scan together. That review usually provides more than a single separate opinion because it places the imaging in your full clinical context.

What if a biopsy is not possible at that site?

Some sites are genuinely difficult or risky to biopsy. Where tissue sampling is not safely feasible, your team may use interval imaging and clinical assessment, or arrange a different imaging test for more information. Ask what they believe the most likely cause is and what change would prompt them to investigate further. An unexplained finding should not be left without an agreed plan.

Will the uptake go away on its own if it is inflammation?

If the cause is post-radiation inflammation, uptake generally does decrease over time as the tissue heals — though the timeline varies and cannot be predicted precisely. This is one reason interval imaging is useful: a follow-up scan showing uptake resolving adds confidence to an inflammatory explanation. Whether that is enough reassurance, or whether tissue confirmation is still needed, depends on your full clinical picture. That decision belongs with your treating team.

Call now Book free consultation